Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Puech

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
BJU International|August 7, 2025
Quantification of prostate cancer Gleason pattern 4 to predict oncological outcomeJonathan Olivier, Emily Vertosick, Luc Delobel, et al.
Frontiers in Oncology|February 22, 2020
Imaging for Metastasis in Prostate Cancer: A Review of the LiteratureAnthony Turpin, Edwina Girard, Clio Baillet, et al.
World Journal of Urology|May 13, 2014
The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancerFrançois Marliere, Philippe Puech, Ahmed Benkirane, et al.
Therapeutic Advances in Urology|August 30, 2021
Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applicationsDenis Séguier, Philippe Puech, Ronald Kool, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 26, 2015
Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancerMustapha Azahaf, Marc Haberlay, Nacim Betrouni, et al.
The French Journal of Urology|December 22, 2024
Long-term oncological outcomes of active surveillance for low-risk prostate cancer diagnosed during the MRI eraToufik Benheddi, Denis Seguier, Philippe Puech, et al.
The Journal of Urology|March 10, 2015
Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients Considered for Active Surveillance for Clinically Low Risk Prostate Cancer Based on Systematic BiopsiesAdil Ouzzane, Raphaele Renard-Penna, François Marliere, et al.
The Journal of Urology|October 20, 2020
Negative Prebiopsy Magnetic Resonance Imaging and Risk of Significant Prostate Cancer: Baseline and Long-Term Followup ResultsJulie Buisset, Joseph M Norris, Philippe Puech, et al.
Urology|August 16, 2011
Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and gradingAdil Ouzzane, Philippe Puech, Laurent Lemaitre, et al.
Urology|September 24, 2009
Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimensPhilippe Puech, Eric Potiron, Laurent Lemaitre, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
BJU International|August 7, 2025
Quantification of prostate cancer Gleason pattern 4 to predict oncological outcomeJonathan Olivier, Emily Vertosick, Luc Delobel, et al.
Frontiers in Oncology|February 22, 2020
Imaging for Metastasis in Prostate Cancer: A Review of the LiteratureAnthony Turpin, Edwina Girard, Clio Baillet, et al.
World Journal of Urology|May 13, 2014
The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancerFrançois Marliere, Philippe Puech, Ahmed Benkirane, et al.
Therapeutic Advances in Urology|August 30, 2021
Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applicationsDenis Séguier, Philippe Puech, Ronald Kool, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 26, 2015
Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancerMustapha Azahaf, Marc Haberlay, Nacim Betrouni, et al.
The French Journal of Urology|December 22, 2024
Long-term oncological outcomes of active surveillance for low-risk prostate cancer diagnosed during the MRI eraToufik Benheddi, Denis Seguier, Philippe Puech, et al.
The Journal of Urology|March 10, 2015
Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients Considered for Active Surveillance for Clinically Low Risk Prostate Cancer Based on Systematic BiopsiesAdil Ouzzane, Raphaele Renard-Penna, François Marliere, et al.
The Journal of Urology|October 20, 2020
Negative Prebiopsy Magnetic Resonance Imaging and Risk of Significant Prostate Cancer: Baseline and Long-Term Followup ResultsJulie Buisset, Joseph M Norris, Philippe Puech, et al.
Urology|August 16, 2011
Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and gradingAdil Ouzzane, Philippe Puech, Laurent Lemaitre, et al.
Urology|September 24, 2009
Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimensPhilippe Puech, Eric Potiron, Laurent Lemaitre, et al.
Pageof 9